相关实验视频

Updated: Jan 15, 2026

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

针对精密免疫疗法的化物-HLA复合体

Jie Bi¹, Lingxiao Jiang¹, Jiaqi Zhao¹

¹Laboratory of Precision Medicine and Biopharmaceuticals, School of Pharmacy, Zhejiang University, Hangzhou, China.

Trends in pharmacological sciences

|January 13, 2026

概括

精密免疫疗法针对特定的-人白细胞抗原 (pHLA) 复合体进行选择性细胞消除. 人工智能和合成生物学方面的进步加速了针对各种疾病的新型pHLA治疗方法的开发.

科学领域:

免疫学免疫学免疫学
生物技术是生物技术.
计算生物学计算生物学

背景情况:

精确免疫疗法旨在通过免疫系统消除异常细胞.
向人白细胞抗原 (pHLA) 复合体提供了特定的干预,因为在健康组织中表达最小.
设计具有低交叉活性的高特异性pHLA结合剂仍然是一个重大挑战.

研究的目的:

审查目前的方法和新兴技术在pHLA向免疫疗法.
讨论基于pHLA的治疗方法的机制,临床前和临床数据.
突出AI和计算设计在推进pHLA向治疗中的作用.

主要方法:

T细胞受体 (TCR) 模仿抗体 (TCRm) 和新的 pHLA 结合剂设计.
开发T细胞参与剂和采用细胞疗法.
人工智能 (AI),免疫学和计算蛋白质设计的应用.

主要成果:

像TCRm和de novo结合剂这样的合成方法显示出有希望的特异性和有效性.
人工智能驱动的方法和计算设计加速了pHLA疗法的发现.
新兴技术正在实现针对PHLA的治疗方法的泛基开发.

结论:

针对pHLA的免疫疗法在治疗癌症,自身免疫和传染病方面是一个有希望的前沿.
合成生物学和人工智能的持续进步对于实现这些疗法的全部潜力至关重要.
该领域正在迅速发展,显著的临床前和临床数据正在出现.

关键词:

这种T细胞的参与者是T细胞.这就是TCR-T.这是一种TCR模仿抗体.新设计的蛋白质酸HLA复合体的酸.可溶性TCR的使用情况

更多相关视频

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...